2 news items
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
CNTB
22 May 24
of its plans will be achieved. Actual data may differ materially from those set forth in this release due to the risks and uncertainties inherent
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
CNTB
16 Apr 24
not be regarded as a representation by Connect Biopharma that any of its plans will be achieved. Actual data may differ materially from those set forth
- Prev
- 1
- Next